OS Therapies’ cancer vaccine, OST-HER2, has been shown to significantly improve overall survival (OS) in patients with recurrent, fully resected, pulmonary metastatic osteosarcoma after two years.

If developing drugs for metabolic dysfunction-associated steatohepatitis (MASH) were a poker game, you could say Novo Nordisk (NASDAQ Copenhagen: NOVO-B) saw a competitor’s bet and raised the stakes ...

Pfizer shares surged 14% over two trading days this past week after joining with Trump’s administration to announce an agreement they positioned as both bolstering U.S. leadership in biopharma ...

Abstract: Unmanned aerial vehicles (UAVs) have found numerous applications and are expected to bring fertile business opportunities in the next decade. Among various enabling technologies for UAVs, ...

Skye Biosciences pipeline obesity drug, nimacimab, has failed to trigger significant weight loss as a monotherapy in a proof-of-concept Phase IIa trial. Image credit: Yellow_man / Shutterstock.com ...

The 9-passenger cabin consists of six VIP seats and an aft three place divan. The forward zone has four VIP seats in a double club configuration. The aft zone has two VIP seats on the righthand side ...

OS Therapies’ cancer vaccine, OST-HER2, has offered improvements to overall survival (OS) in a Phase II trial in METS osteosarcoma. Image credit: sweet_tomato via ShutterStock.com. OS Therapies’ ...

This is a useful tool for code-less analysis of patterns in cell migratory behaviours in vivo using intravital microscopy data and allows correlation with spatial features of the tumour ...

Molecular Imaging Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892-1088, and Graduate School of Pharmaceutical ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.

Generate automated tests for your Node.js app via LLMs without developers having to write a single line of code.